Lucius Partners LLC → Palomino Laboratories Inc. PALX

Stake: 23.00% Shares: 4,000,000 CUSIP: 000000000 Class: Common Stock, $0.0001 par value per share

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 14/100 · Filer 90d Win Rate: 0% · Hist. 90d Edge: +0.0%

Passive Schedule 13G filer baseline
High conviction ownership stake (23.0%)
74 NPORT-P mutual funds holding CUSIP

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

2 transactions

2 buys · 0 sales · 0 awards/exercises

Issuer Cluster

2 13D/G filings on this issuer

1 other filing besides this one

Filer Track Record

3 filings by this filer

2 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 1.00

13 shares short · -95.7% vs prior

Post-Filing Returns · since 2025-09-29 on PALX

+1 day

0.0%

+5 days

0.0%

+30 days

0.0%

+60 days

0.0%

+90 days

0.0%

+180 days

0.0%

Anchor price 4.86 on closest trading day on/after 2025-09-29. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-04-20	Ogawa Richard	director, officer	Buy	12,500	$4.00	$50K
2026-04-20	Denbaars Steven	director	Buy	12,500	$4.00	$50K

Other 13D/G Filings on Palomino Laboratories Inc.

Filed	Form	Filer	Stake	Shares
2026-08-21	SCHEDULE 13D/A	Ogawa Richard	6.90%	1,882,500	view →

Other Filings by Lucius Partners LLC

Filed	Form	Issuer	Stake	Shares
2026-09-09	SCHEDULE 13D/A	Blue Laser Fusion, Inc.	—	1,000,000	view →
2026-09-09	SCHEDULE 13D	Blue Laser Fusion, Inc.	100.00%	5,000,000	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →